Active, Not Recruiting
A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
NCT06521567
- Conditions
- Adenocarcinoma, Astrocytoma, Brain Diseases, +56 more
- Locations
-
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site Iowa City, Iowa, United States
- GSK Investigational Site Hackensack, New Jersey, United States
- GSK Investigational Site Cincinnati, Ohio, United States